Transforming Growth Factor

Chronic Allograft Rejection;Transplantation;T Regulatory Cells;IL-17;Transforming Growth Factor β (TGFβ);Fibrosis;Microbiology and Immunology;Science;Cellular & Molecular Biology

Faust, Susan MarieMoore, Bethany B. ;

University of Michigan

关键词: Chronic Allograft Rejection;    Transplantation;    T Regulatory Cells;    IL-17;    Transforming Growth Factor β (TGFβ);    Fibrosis;    Microbiology and Immunology;    Science;    Cellular & Molecular Biology;   

Others  :  https://deepblue.lib.umich.edu/bitstream/handle/2027.42/64611/smfaust_1.pdf?sequence=1&isAllowed=y

瑞士|英语

来源: The Illinois Digital Environment for Access to Learning and Scholarship

【 摘 要 】

Chronic allograft rejection (CR) is the main barrier to long-term transplant survival. CR is a progressive disease defined by interstitial fibrosis, vascular neointimal development, and graft dysfunction. The underlying mechanisms responsible for CR remain poorly defined, although transforming growth factor β (TGFβ) has been strongly implicated in promoting fibrotic diseases and CR. However, TGFβ is a suppressive cytokine, which may be beneficial in the transplant setting. Hence, an in depth assessment of the fibrotic and anti-inflammatory activities of TGFβ in cardiac transplant was performed.In this study, the role of TGFβ on graft-reactive cellular and humoral responses, T regulatory cell (Treg) function, allograft acceptance and the progression of CR are assessed. These studies identify TGFβ dependent and independent pathways to allograft acceptance, and investigate the contribution of TGFβ-induced IL-17 in the progression of CR. Since TGFβ exhibits exacerbating or ameliorating characteristics depending on the site of action, TGFβ neutralization within the allograft addresses local TGFβ inhibition on fibrosis and graft-reactive T and B cell responses. Studies in this dissertation provide insight into the underlying causes of CR and identify therapeutic targets for treatment of this disease.